Symposium:
7. Zika Zymposium I: Epidemiology, Virology, and Countermeasures
Wednesday, October 26, 2016: 1:30 PM-3:30 PM
Room: Theater A & B

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the epidemiology of the current outbreak and future prospects

  • describe the virology and pathogenic mechanisms of Zika virus

  • describe the countermeasures to fight the virus, including candidate vaccines, monoclonal antibodies, diagnostics, and therapeutics

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Pediatric ID, Global ID

Moderator:  Ravi Jhaveri, MD, FIDSA, FPIDS, University of North Carolina

Presentations:
1:30 PM
13
Review of the Outbreak
Lyle Petersen, MD, MPH

2:05 PM
Q&A
2:10 PM
14
Zika Virology and Pathogenesis
Helen Lazear, PhD
2:45 PM
Q&A
2:50 PM
15
Zika Countermeasures
Mark J. Mulligan, MD, FIDSA

3:25 PM
Q&A

CME Credits: Maximum of 2.00 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 2 knowledge-based contact hours 0.2 of pharmacy CE

ACPE Number: 0221-9999-16-304-L04-P

Disclosures:

R. Jhaveri, Merck: Grant Investigator , Research grant
Gilead: Investigator , Research grant
Abbvie: Investigator , Research grant
GenMark: Grant Investigator , Research grant
Alios: Investigator , Research grant
MedImmune: Grant Investigator and Scientific Advisor , Have not received anything yet for Advisory role and Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.